Clinic
Dsi Renal INC
Dsi Renal INC was paid $305K by Medicaid between Jan 2018 and Sep 2024, across 18 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 88% of everything it billed.
33Billing provider infoDSI RENAL INC
COVINGTON, GA 30014
COVINGTON, GA 30014
33aNPI1699720011assigned 05/24/2006
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$305K
24GClaims70,311
24DCodes billed18
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Georgia
Rank by total paid#9 of 23
Median peer was paid$137K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,317 | $26K | |
| 2019 | 14,192 | $31K | |
| 2020 | 14,628 | $40K | |
| 2021 | 11,833 | $57K | |
| 2022 | 8,948 | $73K | |
| 2023 | 3,552 | $38K | |
| 2024incomplete | 1,841 | $40K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 88% | 26,217 | 2,052 | $267K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11% | 21,429 | 1,096 | $34K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 3,333 | 848 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 12,475 | 1,048 | $903.53 |
| 82728 | <1% | 569 | 503 | $651.31 | |
| 82108 | <1% | 91 | 80 | $130.40 | |
| A4657 | Syringe, with or without needle, each | 0% | 1,329 | 1,256 | $0.00 |
| 83550 | 0% | 538 | 471 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 49 | 48 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 0% | 63 | 52 | $0.00 |
| 90674 | 0% | 39 | 38 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 0% | 40 | 24 | $0.00 |
6 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARR, GRETCHEN (VP OF REIMBURSEMENT)